ARTICLE | Company News
Iroko, EMS deal
August 11, 2014 7:00 AM UTC
Iroko granted EMS exclusive rights to commercialize pain drug Zorvolex submicron diclofenac in Brazil. EMS will be responsible for regulatory and pricing approval in Brazil. Iroko said EMS plans to s...